Results of interim analysis of a retrospective IGIBD study on adalimumab use in real practice in Italy: the REAL-life clinical effectiveness of ADAlimumab in ulcerative colitis

被引：0

作者：

Pugliese, D. ^{[1
]}

Mendolaro, M. ^{[2
]}

D'Inca, R. ^{[3
]}

Ribaldone, D. G. ^{[4
]}

Principi, M. ^{[5
]}

Ricci, C. ^{[6
]}

Stasi, E. ^{[7
]}

Scribano, M. L. ^{[8
]}

Bodini, G. ^{[9
]}

Saibeni, S. ^{[10
]}

Privitera, A. C. ^{[11
]}

Simondi, D. ^{[12
]}

Armuzzi, A. ^{[1
]}

Daperno, M. ^{[2
]}

机构：

[1] Fdn Policlin Gemelli IRCCS, Gastroenterol, Rome, Italy

[2] Mauriziano Hosp, Gastroenterol Unit, Turin, Italy

[3] Univ Padua, Gastroenterol Unit, Padua, Italy

[4] Citta Sci & Salute, Gastroenterol Unit, Turin, Italy

[5] Bari Univ, Gastroenterol Unit, Bari, Italy

[6] Spedali Civil Brescia, Internal Med, Brescia, Italy

[7] IRCCS De Bellis, Gastroenterol Unit, Castellana Grotte, Italy

[8] S Camillo Forlanini Hosp, Gastroenterol Unit, Rome, Italy

[9] Genova Univ Hosp, Gastroenterol Unit, Genoa, Italy

[10] Rho Hosp, Gastroenterol Unit, Rho, Italy

[11] Cannizzaro Hosp, Gastroenterol Unit, Catania, Italy

[12] S Croce & Carle Hosp, Gastroenterol Unit, Cuneo, Italy

来源：

JOURNAL OF CROHNS & COLITIS | 2019年 / 13卷

关键词：

D O I：

10.1093/ecco-jcc/jjy222.636

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

P512

引用

页码：S369 / S369

页数：1

共 50 条

[21] Real-Life Effectiveness of Adalimumab Biosimilars in Patients with Chronic Plaque Psoriasis
Francesco Bellinato
Paolo Gisondi
Elena Mason
Paolo Ricci
Martina Maurelli
Giampiero Girolomoni
Dermatology and Therapy, 2022, 12 : 1303 - 1311
[22] Real-Life Effectiveness of Adalimumab Biosimilars in Patients with Chronic Plaque Psoriasis
Bellinato, Francesco
Gisondi, Paolo
Mason, Elena
Ricci, Paolo
Maurelli, Martina
Girolomoni, Giampiero
DERMATOLOGY AND THERAPY, 2022, 12 (06) : 1303 - 1311
[23] Real-life Tolerability and Effectiveness of Adalimumab Biosimilar in Ankylosing Spondylitis: the Adalimumab Biosimilar Patient Registry Data
Kapoor, Sanjiv
Kaushik, Viswanath V.
Jain, Rahul
Rao, Vijay K. R.
Gharia, Mihir
ACR OPEN RHEUMATOLOGY, 2019, 1 (08) : 480 - 484
[24] Ustekinumab safety and effectiveness in patients with ulcerative colitis: results from a large real-life study
Tursi, Antonio
Mocci, Giammarco
Scaldaferri, Franco
Napolitano, Daniele
Maresca, Rossella
Pugliese, Daniela
Semprucci, Gianluca
Savarino, Edoardo
Cuomo, Antonio
Donnarumma, Laura
Bodini, Giorgia
Pasta, Andrea
Maconi, Giovanni
Cataletti, Giovanni
Pranzo, Giuseppe
Rodino, Stefano
Sebkova, Ladislava
Costa, Francesco
Ferronato, Antonio
Gaiani, Federica
Marzo, Manuela
Luppino, Ileana
Fabiano, Giulia
Paese, Pietro
Elisei, Walter
Monterubbianesi, Rita
Faggiani, Roberto
Grossi, Laurino
Serio, Mariaelena
Scarcelli, Antonella
Lorenzetti, Roberto
Allegretta, Leonardo
Chiri, Stefania
Grasso, Giuseppina
Antonelli, Elisabetta
Bassotti, Gabrio
Spagnuolo, Rocco
Luzza, Francesco
Fanigliulo, Libera
Rocco, Giulia
Sacchi, Carlotta
Zampaletta, Costantino
Rocchi, Chiara
Bolognini, Laura
Bendia, Emanuele
Bianco, Maria Antonia
Capone, Pietro
Meucci, Costantino
Colucci, Raffaele
Tonti, Paolo
EXPERT OPINION ON BIOLOGICAL THERAPY, 2024, 24 (1-2) : 101 - 109
[25] Ustekinumab safety and effectiveness in ulcerative colitis patients: results from a large real-life study
Mocci, G.
Scaldaferri, F.
Pugliese, D.
Savarino, E.
Bodini, G.
Cuomo, A.
Donnarumma, L.
Maconi, G.
Cataletti, G.
Rodino, S.
Sebkova, L.
Ferronato, A.
Gaiani, F.
Marzo, M.
Luppino, I.
Paese, P.
Elisei, W.
Monterubbianesi, R.
Faggiani, R.
Napolitano, D.
Grossi, L.
Serio, M.
Scarcelli, A.
Lorenzetti, R.
Allegretta, L.
Rocco, G.
Zampaletta, C.
Bolognini, L.
Meucci, C.
Colucci, R.
Tonti, P.
Della Valle, N.
Piga, R.
Forti, G.
Onidi, F. M.
Satta, P. Usai
Picchio, M.
Papa, A.
Tursi, A.
JOURNAL OF CROHNS & COLITIS, 2024, 18 : I1065 - I1066
[26] Efficacy and Safety of Adalimumab in Pediatric Ulcerative Colitis: A Real-life Experience from the SIGENP-IBD Registry
Aloi, Marina
Bramuzzo, Matteo
Arrigo, Serena
Romano, Claudio
D'Arcangelo, Giulia
Lacorte, Doriana
Gatti, Simona
Illiceto, Maria T.
Zucconi, Francesca
Dilillo, Dario
Zuin, Giovanna
Knafelz, Daniela
Ravelli, Alberto
Cucchiara, Salvatore
Alvisi, Patrizia
JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION, 2018, 66 (06): : 920 - 925
[27] REAL-LIFE PROSPECTIVE EXPERIENCE WITH ADALIMUMAB IN INDUCING REMISSION IN ULCERATIVE COLITIS IN PRIMARY INFLAMMATORY BOWEL DISEASES CENTRES
Tursi, A.
Allegretta, L.
Della Valle, N.
Elisei, W.
Forti, G.
Faggiani, R.
Lorenzetti, R.
Mocci, G.
Penna, A.
Pranzo, G.
Paiano, P.
Ricciardelli, C.
Zampaletta, C.
Picchio, M.
DIGESTIVE AND LIVER DISEASE, 2017, 49 : E210 - E211
[28] Adalimumab (Humira®) is effective in treating patients with psoriatic arthritis (PSA) in real-life clinical practice:: Results of the stereo trial
van den Bosch, F.
Manger, B.
Goupille, P.
McHugh, N.
Roedevand, E.
Holck, P.
van Vollenhoven, R.
Leirisalo-Repo, M.
FitzGerald, O.
Frank, C.
Kron, M.
Frank, M.
Kupper, H.
ANNALS OF THE RHEUMATIC DISEASES, 2007, 66 : 98 - 98
[29] Efficacy and safety of adalimumab in the treatment of Rheumatoid Arthritis (RA) in real-life clinical practice: 1-year-results of the react study
Burmester, G. R.
Wordsworth, P.
Saez, I. Monteagudo
Malaise, M. G.
Kary, S.
Kupper, H.
RHEUMATOLOGY, 2006, 45 : I43 - I43
[30] Infliximab Originator, Infliximab Biosimilar, and Adalimumab Are More Effective in Crohn's Disease Than Ulcerative Colitis: A Real-Life Cohort Study
Barberio, Brigida
Zingone, Fabiana
D'Inca, Renata
Rovigo, Laura
Bertani, Lorenzo
Bodini, Giorgia
Ghisa, Matteo
Gubbiotti, Alessandro
Massimi, Davide
Lorenzon, Greta
Savarino, Edoardo Vincenzo
CLINICAL AND TRANSLATIONAL GASTROENTEROLOGY, 2020, 11

← 1 2 3 4 5 →